Amid rising concern about the potential long-term costs of using glucagon-like peptide 1 (GLP-1) agonists to treat obesity, some insurers are making access to bariatric surgery […]

TOPLINE: Higher urinary magnesium loss, as indicated by an elevated magnesium depletion score (MDS), may be an independent risk factor for metabolic syndrome in US adults. […]

TOPLINE: The addition of supervised exercise to obesity pharmacotherapy has shown greater potential for maintaining weight loss and improving body composition after treatment termination than pharmacotherapy […]

Among adolescents with moderate to severe obesity, a nutritionally balanced, very low-calorie diet with the monitoring of a dietician shows high adherence and safety, with significant […]

TOPLINE: Sodium-glucose cotransporter 2 inhibitor (SGLT2i)-associated diabetes ketoacidosis (DKA) in people with type 2 diabetes (T2D) is associated with lower degrees of hyperglycemia over the first […]

TOPLINE: Women who experience gestational diabetes mellitus (GDM) earlier (< 20 weeks) in pregnancy may have worse birth outcomes than other women with late GDM who […]

TOPLINE: In people with type 2 diabetes (T2D) and peripheral artery disease (PAD), liraglutide significantly increased peripheral perfusion over 6 months compared with conventional treatment of […]

A novel vibrating capsule that signals a postprandial feeling of fullness reduced both food and energy intake and lowered weight gain in animal studies, said researchers […]

The US Food and Drug Administration (FDA) has cleared the twiist automated insulin delivery (AID) system (Sequel Med Tech, LLC; Manchester, NH) for people aged 6 […]